104 related articles for article (PubMed ID: 9915384)
1. Nonselective debridement and antimicrobial cleansing of a venting ductal breast carcinoma.
Nash MS; Nash LH; Garcia RG; Neimark P
Arch Phys Med Rehabil; 1999 Jan; 80(1):118-21. PubMed ID: 9915384
[TBL] [Abstract][Full Text] [Related]
2. Wound management with whirlpool and infrared cold laser treatment. A clinical report.
Gogia PP; Hurt BS; Zirn TT
Phys Ther; 1988 Aug; 68(8):1239-42. PubMed ID: 3399522
[TBL] [Abstract][Full Text] [Related]
3. Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy.
Thomas F; Arriagada R; Spielmann M; Mouriesse H; Le Chevalier T; Fontaine F; Tursz T
Cancer; 1995 Dec; 76(11):2286-90. PubMed ID: 8635033
[TBL] [Abstract][Full Text] [Related]
4. The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
Fowble B; Hanlon AL; Patchefsky A; Freedman G; Hoffman JP; Sigurdson ER; Goldstein LJ
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):105-15. PubMed ID: 9747827
[TBL] [Abstract][Full Text] [Related]
5. Dose-intensive therapy for breast cancer.
O'Shaughnessy JA; Cowan KH
JAMA; 1993 Nov; 270(17):2089-92. PubMed ID: 8411576
[No Abstract] [Full Text] [Related]
6. A 35-Year-Old Woman With a Change in HER2 Expression Following Neoadjuvant Chemotherapy for Invasive Breast Cancer.
Stoen E; Kabos P; Borden KC; Brown RJ; Borges VF; Diamond JR
Oncology (Williston Park); 2018 Jun; 32(6):298-302. PubMed ID: 29940061
[No Abstract] [Full Text] [Related]
7. Pathologic response to short intensified taxane-free neoadjuvant chemotherapy in patients with highly proliferative operable breast cancer.
Le Tourneau C; Dettwiler S; Beuzeboc P; Alran S; Laurence V; Pierga JY; Fréneaux P; Sigal-Zafrani B; Diéras V; Vincent-Salomon A
Am J Clin Oncol; 2012 Jun; 35(3):242-6. PubMed ID: 21358298
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy analysis of THP-containing regimens as neoadjuvant and adjuvant chemotherapy for primary breast cancer].
Wang LZ; Ouyang T; Wang TF; Xie YT; Fan ZQ; Fan T; Lin BY; Li JF
Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):143-6. PubMed ID: 22780935
[TBL] [Abstract][Full Text] [Related]
9. Histologic grade of locally advanced infiltrating ductal carcinoma after treatment with induction chemotherapy.
Frierson HF; Fechner RE
Am J Clin Pathol; 1994 Aug; 102(2):154-7. PubMed ID: 8042581
[TBL] [Abstract][Full Text] [Related]
10. Wound care in venous ulcers.
Mosti G
Phlebology; 2013 Mar; 28 Suppl 1():79-85. PubMed ID: 23482540
[TBL] [Abstract][Full Text] [Related]
11. Wound bed preparation: A novel approach using HydroTherapy.
Atkin L; Ousey K
Br J Community Nurs; 2016 Dec; 21(Sup12):S23-S28. PubMed ID: 27922792
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of neoadjuvant chemotherapy with FEC and TEC regimen on breast cancer].
Wang B; Fu JF; Hong ZW
Ai Zheng; 2009 Mar; 28(3):292-6. PubMed ID: 19619445
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging in predicting pathological response of triple negative breast cancer following neoadjuvant chemotherapy.
Chen JH; Mehta RS; Carpenter PM; Nalcioglu O; Su MY
J Clin Oncol; 2007 Dec; 25(35):5667-9. PubMed ID: 18065744
[No Abstract] [Full Text] [Related]
14. The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients.
Stamatovic L; Susnjar S; Gavrilovic D; Minic I; Ursulovic T; Dzodic R
J BUON; 2018; 23(5):1273-1280. PubMed ID: 30570847
[TBL] [Abstract][Full Text] [Related]
15. Old school regimen may turn the tide in metastatic breast cancer.
Gezgen G; Roach EC; Kizilarslanoglu MC; Altundag K
J BUON; 2011; 16(4):781. PubMed ID: 22331741
[No Abstract] [Full Text] [Related]
16. Doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvant chemotherapy in breast cancer.
Livi L; Saieva C; Borghesi S; De Luca Cardillo C; Scotti V; Mangoni M; Greto D; Cataliotti L; Paiar F; Bianchi S; Biti GP
J Chemother; 2009 Nov; 21(5):558-65. PubMed ID: 19933048
[TBL] [Abstract][Full Text] [Related]
17. Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm.
Calais G; Berger C; Descamps P; Chapet S; Reynaud-Bougnoux A; Body G; Bougnoux P; Lansac J; Le Floch O
Cancer; 1994 Aug; 74(4):1283-8. PubMed ID: 8055449
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of the therapeutic effect of CMxMF and CAMF regimens in the management of advanced breast cancer patients].
Chen JA
Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):202-4. PubMed ID: 8261866
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy for locally advanced premenopausal breast cancer in Nigerian women: early experience.
Anyanwu SN; Nwose P; Ihekwoaba E; Mbaeri AT; Chukwuanukwu TO
Niger J Clin Pract; 2010 Jun; 13(2):215-7. PubMed ID: 20499759
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer.
Pierga JY; Mouret E; Diéras V; Laurence V; Beuzeboc P; Dorval T; Palangié T; Jouve M; Vincent-Salomon A; Scholl S; Extra JM; Asselain B; Pouillart P
Br J Cancer; 2000 Dec; 83(11):1480-7. PubMed ID: 11076657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
